July 3 CBP Bulletin Modifies Rulings on NAFTA Country of Origin Marking of Apomorphine Hydrochloride Ampoules
In the July 3 issue of the Customs Bulletin (Vol. 47, No. 28), CBP published two notices of revocation of rulings and treatment regarding drawback of processed prunes and the classification of valve cable supports.
Revocations Are Effective Sept. 3
CBP is modifying these rulings, as well as any treatment CBP previously accorded to substantially identical transactions, effective for merchandise entered or withdrawn from warehouse for consumption on or after Sept. 3.
Apomorphine Hydrochloride Ampoules
| Item: Apomorphine Hydrochloride Ampoules. Apomorphine hydrochloride is produced in France and exported to Canada. Sodium hydroxide is produced in Sweden and exported to Canada. Hydrochloric acid is produced in the U.S. and exported to Canada. In Canada, the three ingredients are mixed and put up in ampoules, packaged, labeled, and shipped to the U.S. |
| New Ruling: HQ H200037 (dated 05/21/13), modifies NY I88116 (2002) |
| Old Ruling: The country of origin of the imported ampoules is the country or countries of origin of the single material that imparts the essential character to them. In this case, the essential character is imparted by the active ingredient, (the French-produced) Apomorphine Hydrochloride. The country of origin is therefore France. |
| New Ruling: The country of origin is Canada. |
| Reason: The good satisfies the General Note 12 tariff shift rule. The manufacturing that occurs in Canada in this case is more than minor processing, and because the apomorphine hydrochloride ampoules underwent production other than minor processing in Canada, the country of origin for marking purposes under the NAFTA Marking Rules is Canada. |
(See ITT's Online Archives 13050116 for summary of the proposed revocation of this ruling.)